2024
DOI: 10.4239/wjd.v15.i7.1518
|View full text |Cite
|
Sign up to set email alerts
|

Dapagliflozin in heart failure and type 2 diabetes: Efficacy, cardiac and renal effects, safety

Pei-Ling Yu,
You Yu,
Shuang Li
et al.

Abstract: BACKGROUND Heart failure (HF), especially HF with reduced ejection fraction (HFrEF), presents complex challenges, particularly in the aging population where it often coexists with type 2 diabetes mellitus (T2DM). AIM To analyze the effect of dapagliflozin treatment on cardiac, renal function, and safety in patients with HFrEF combined with T2DM. METHODS Patients with T2DM complicated with HFrEF who underwent treatment in our hospital from February 2018 to March… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 39 publications
0
0
0
Order By: Relevance